Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Rhabdomyosarcoma
  • Soft Tissue Neoplasms

abstract

  • Age, location, nodal status, and histologic subtype do not appear be associated with survival in adults with rhabdomyosarcoma treated with multimodal therapy. Metastatic disease at presentation and poor response to chemotherapy are strongly associated with poor prognosis. Future systemic therapies should be targeted to patients with localized/locoregional disease and partial responders to conventional chemotherapy.

publication date

  • August 20, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC1422009

PubMed ID

  • 11505068

Additional Document Info

start page

  • 215

end page

  • 23

volume

  • 234

number

  • 2